FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

108831000001105: NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 22-Jan 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1133261000001118 Clinical Trial en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1133271000001111 NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial (qualifier value) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1133281000001113 NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Is a NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
COVID-19 Vaccine Moderna (mRNA-1273.214) 50micrograms/0.5ml dose dispersion for injection vials (Moderna, Inc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
COVID-19 Vaccine Nuvaxovid (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection multidose vials (Novavax CZ a.s.) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
COVID-19 Vaccine Nuvaxovid (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection multidose vials (Novavax CZ a.s.) 100 dose 10 x 10 dose vials Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
COVID-19 Vaccine Nuvaxovid (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection multidose vials (Novavax CZ a.s.) 10 dose Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Imdevimab 120mg/ml solution for infusion 2.5ml vials (Roche Products Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Asciminib 40mg tablets (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Asciminib 20mg tablets (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Casirivimab 120mg/ml solution for infusion 2.5ml vials (Roche Products Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Casirivimab 120mg/ml solution for infusion 2.5ml vials and Imdevimab 120mg/ml solution for infusion 2.5ml vials (Roche Products Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Comirnaty Children 5-11 years COVID-19 mRNA Vaccine 10micrograms/0.2ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Sotrovimab 500mg/8ml solution for infusion vials (GlaxoSmithKline UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Sotrovimab 500mg/8ml solution for infusion vials (GlaxoSmithKline UK Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Comirnaty Children 5-11 years COVID-19 mRNA Vaccine 10micrograms/0.2ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd) 10 dose Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Comirnaty Children 5-11 years COVID-19 mRNA Vaccine 10micrograms/0.2ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd) 100 dose 10 x 10 dose vials Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
COVID-19 Vaccine AZD2816 AstraZeneca (ChAdOx1 nCOV-19) 3.5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials (AstraZeneca AB) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
COVID-19 Vaccine AZD2816 AstraZeneca (ChAdOx1 nCOV-19) 3.5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials (AstraZeneca AB) 10 dose Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
COVID-19 Vaccine Sanofi (CoV2 preS dTM monovalent D614 [recombinant]) 5micrograms/0.5ml dose suspension for injection multidose vials (Sanofi Pasteur) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Comirnaty Children 6 months - 4 years COVID-19 mRNA Vaccine 3micrograms/0.2ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
COVID-19 Vaccine Sanofi (CoV2 preS dTM monovalent D614 [recombinant]) 5micrograms/0.5ml dose suspension for injection multidose vials (Sanofi Pasteur) 10 dose Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
COVID-19 Vaccine Moderna (mRNA-1273.214) 50micrograms/0.5ml dose dispersion for injection vials (Moderna, Inc) 1 dose Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Asciminib 20mg tablets (Novartis Pharmaceuticals UK Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Asciminib 40mg tablets (Novartis Pharmaceuticals UK Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
COVID-19 Vaccine Moderna (mRNA-1273.529) 50micrograms/0.25ml dose solution for injection multidose vials (Moderna, Inc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
COVID-19 Vaccine Moderna (mRNA-1273.529) 50micrograms/0.25ml dose solution for injection multidose vials (Moderna, Inc) 2 dose Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Casirivimab 120mg/ml solution for infusion 2.5ml vials and Imdevimab 120mg/ml solution for infusion 2.5ml vials (Roche Products Ltd) 2 vial Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Casirivimab 120mg/ml solution for infusion 2.5ml vials (Roche Products Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Imdevimab 120mg/ml solution for infusion 2.5ml vials (Roche Products Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Casirivimab 120mg/ml solution for infusion 11.1ml vials (Roche Products Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Casirivimab 120mg/ml solution for infusion 11.1ml vials and Imdevimab 120mg/ml solution for infusion 11.1ml vials (Roche Products Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Imdevimab 120mg/ml solution for infusion 11.1ml vials (Roche Products Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Casirivimab 120mg/ml solution for infusion 11.1ml vials and Imdevimab 120mg/ml solution for infusion 11.1ml vials (Roche Products Ltd) 2 vial Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Imdevimab 120mg/ml solution for infusion 11.1ml vials (Roche Products Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Casirivimab 120mg/ml solution for infusion 11.1ml vials (Roche Products Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Comirnaty Children 6 months - 4 years COVID-19 mRNA Vaccine 3micrograms/0.2ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd) 10 dose Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Comirnaty Children 6 months - 4 years COVID-19 mRNA Vaccine 3micrograms/0.2ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd) 100 dose 10 x 10 dose vials Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Casirivimab (REGN10933) 120mg/ml solution for infusion 11.1ml vials (University of Oxford) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Casirivimab (REGN10933) 120mg/ml solution for infusion 11.1ml vials and Imdevimab (REGN10987) 120mg/ml solution for infusion 11.1ml vials (University of Oxford) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Imdevimab (REGN10987) 120mg/ml solution for infusion 11.1ml vials (University of Oxford) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Imdevimab (REGN10987) 120mg/ml solution for infusion 11.1ml vials (University of Oxford) 1 vial Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Casirivimab (REGN10933) 120mg/ml solution for infusion 11.1ml vials (University of Oxford) 1 vial Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Casirivimab (REGN10933) 120mg/ml solution for infusion 11.1ml vials and Imdevimab (REGN10987) 120mg/ml solution for infusion 11.1ml vials (University of Oxford) 2 vial Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
COVID-19 Vaccine Valneva (inactivated adjuvanted whole virus) 40antigen units/0.5ml dose suspension for injection multidose vials (Valneva UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
COVID-19 Vaccine Valneva (inactivated adjuvanted whole virus) 40antigen units/0.5ml dose suspension for injection multidose vials (Valneva UK Ltd) 100 dose 10 x 10 dose vials Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
COVID-19 Vaccine Valneva (inactivated adjuvanted whole virus) 40antigen units/0.5ml dose suspension for injection multidose vials (Valneva UK Ltd) 10 dose Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
COVID-19 Vaccine VidPrevtyn Beta (CoV2 preS dTM monovalent B.1.351 [recombinant adjuvanted]) 5micrograms/0.5ml dose solution and emulsion for emulsion for injection multidose vials (Sanofi Pasteur) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
COVID-19 Vaccine Sanofi (CoV2 preS dTM bivalent D614+B.1.351 [recombinant adjuvanted]) 2.5micrograms/2.5micrograms/0.5ml dose emulsion for injection multidose vials (Sanofi Pasteur) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
COVID-19 Vaccine VidPrevtyn Beta (CoV2 preS dTM monovalent B.1.351 [recombinant adjuvanted]) 5micrograms/0.5ml dose solution and emulsion for emulsion for injection multidose vials (Sanofi Pasteur) 10 dose Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
COVID-19 Vaccine Sanofi (CoV2 preS dTM bivalent D614+B.1.351 [recombinant adjuvanted]) 2.5micrograms/2.5micrograms/0.5ml dose emulsion for injection multidose vials (Sanofi Pasteur) 10 dose Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
COVID-19 Vaccine Medicago (CoVLP) 3.75micrograms/0.5ml dose emulsion for injection multidose vials (Medicago Inc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
COVID-19 Vaccine Medicago (CoVLP) 3.75micrograms/0.5ml dose emulsion for injection multidose vials (Medicago Inc) 10 dose 10x0.5ml (0.25ml+0.25ml) doses Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
COVID-19 Vaccine Medicago (CoVLP) 3.75micrograms/0.5ml dose emulsion for injection multidose vials (Medicago Inc) 100 dose 100x0.5ml(0.25ml+0.25ml) doses Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Remdesivir 100mg powder for concentrate for solution for infusion vials (Gilead Sciences Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Remdesivir 150mg powder for concentrate for solution for infusion vials (Gilead Sciences Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Remdesivir 100mg/20ml concentrate for solution for infusion vials (Gilead Sciences Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Remdesivir 150mg powder for concentrate for solution for infusion vials (Gilead Sciences Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Remdesivir 100mg/20ml concentrate for solution for infusion vials (Gilead Sciences Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Remdesivir 100mg powder for concentrate for solution for infusion vials (Gilead Sciences Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Comirnaty COVID-19 mRNA Vaccine 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd) 8 dose Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd) 10 dose Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Comirnaty COVID-19 mRNA Vaccine 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd) 6 dose Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
Comirnaty COVID-19 mRNA Vaccine 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd) 1170 dose 195 x 6 dose vials Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
COVID-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) 0.5ml dose suspension for injection multidose vials (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
COVID-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) 0.5ml dose suspension for injection multidose vials (Janssen-Cilag Ltd) 50 dose 10 x 5 dose vials Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
COVID-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) 0.5ml dose suspension for injection multidose vials (Janssen-Cilag Ltd) 5 dose Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd) 80 dose 10 x 8 dose vials Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier
COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd) 100 dose 10 x 10 dose vials Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator True NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start